OneCarbon
Company
OneCarbon develops one asset, in human trials (1C-01 in probiotic intervention). Mostly microbiome.
- 1
- Asset
- Furthest stage
- Human trials
- 1
- Trial
- 2
- Signals
Pipeline
1Probiotic supplementation intended to modulate gut microbiota.
Human trials, Microbiome, probiotic intervention
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials1
- Signals2